Literature DB >> 19276438

The public health impact of avian influenza viruses.

J M Katz1, V Veguilla, J A Belser, T R Maines, N Van Hoeven, C Pappas, K Hancock, T M Tumpey.   

Abstract

Influenza viruses with novel hemagglutinin and 1 or more accompanying genes derived from avian influenza viruses sporadically emerge in humans and have the potential to result in a pandemic if the virus causes disease and spreads efficiently in a population that lacks immunity to the novel hemagglutinin. Since 1997, multiple avian influenza virus subtypes have been transmitted directly from domestic poultry to humans and have caused a spectrum of human disease, from asymptomatic to severe and fatal. To assess the pandemic risk that avian influenza viruses pose, we have used multiple strategies to better understand the capacity of avian viruses to infect, cause disease, and transmit among mammals, including humans. Seroepidemiologic studies that evaluate the frequency and risk of human infection with avian influenza viruses in populations with exposure to domestic or wild birds can provide a better understanding of the pandemic potential of avian influenza subtypes. Investigations conducted in Hong Kong following the first H5N1 outbreak in humans in 1997 determined that exposure to poultry in live bird markets was a key risk factor for human disease. Among poultry workers, butchering and exposure to sick poultry were risk factors for antibody to H5 virus, which provided evidence for infection. A second risk assessment tool, the ferret, can be used to evaluate the level of virulence and potential for host-to-host transmission of avian influenza viruses in this naturally susceptible host. Avian viruses isolated from humans exhibit a level of virulence and transmissibility in ferrets that generally reflects that seen in humans. The ferret model thus provides a means to monitor emerging avian influenza viruses for pandemic risk, as well as to evaluate laboratory-generated reassortants and mutants to better understand the molecular basis of influenza virus transmissibility. Taken together, such studies provide valuable information with which we can assess the public health risk of avian influenza viruses.

Entities:  

Mesh:

Year:  2009        PMID: 19276438     DOI: 10.3382/ps.2008-00465

Source DB:  PubMed          Journal:  Poult Sci        ISSN: 0032-5791            Impact factor:   3.352


  16 in total

1.  Beta-defensin 2 enhances immunogenicity and protection of an adenovirus-based H5N1 influenza vaccine at an early time.

Authors:  Sai V Vemula; Omar Amen; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  Virus Res       Date:  2013-09-17       Impact factor: 3.303

2.  Natural Reassortants of Potentially Zoonotic Avian Influenza Viruses H5N1 and H9N2 from Egypt Display Distinct Pathogenic Phenotypes in Experimentally Infected Chickens and Ferrets.

Authors:  Mahmoud M Naguib; Reiner Ulrich; Elisa Kasbohm; Christine L P Eng; Donata Hoffmann; Christian Grund; Martin Beer; Timm C Harder
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

3.  Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins.

Authors:  Katherine A Richards; Francisco A Chaves; Shabnam Alam; Andrea J Sant
Journal:  Vaccine       Date:  2012-10-22       Impact factor: 3.641

4.  Molecular characterization of mammalian-adapted Korean-type avian H9N2 virus and evaluation of its virulence in mice.

Authors:  Kuk Jin Park; Min-Suk Song; Eun-Ha Kim; Hyeok-Il Kwon; Yun Hee Baek; Eun-Hye Choi; Su-Jin Park; Se Mi Kim; Young-Il Kim; Won-Suk Choi; Dae-Won Yoo; Chul-Joong Kim; Young Ki Choi
Journal:  J Microbiol       Date:  2015-07-31       Impact factor: 3.422

5.  A synthetic adjuvant to enhance and expand immune responses to influenza vaccines.

Authors:  Rhea N Coler; Susan L Baldwin; Narek Shaverdian; Sylvie Bertholet; Steven J Reed; Vanitha S Raman; Xiuhua Lu; Joshua DeVos; Kathy Hancock; Jacqueline M Katz; Thomas S Vedvick; Malcolm S Duthie; Christopher H Clegg; Neal Van Hoeven; Steven G Reed
Journal:  PLoS One       Date:  2010-10-27       Impact factor: 3.240

6.  DNA microarray global gene expression analysis of influenza virus-infected chicken and duck cells.

Authors:  Suresh V Kuchipudi; Stephen P Dunham; Kin-Chow Chang
Journal:  Genom Data       Date:  2015-03-20

7.  Highly pathogenic avian influenza virus infection in chickens but not ducks is associated with elevated host immune and pro-inflammatory responses.

Authors:  Suresh V Kuchipudi; Meenu Tellabati; Sujith Sebastian; Brandon Z Londt; Christine Jansen; Lonneke Vervelde; Sharon M Brookes; Ian H Brown; Stephen P Dunham; Kin-Chow Chang
Journal:  Vet Res       Date:  2014-11-28       Impact factor: 3.683

8.  Influenza virus assays based on virus-inducible reporter cell lines.

Authors:  Yunsheng Li; Audrey Larrimer; Teresa Curtiss; Jaekyung Kim; Abby Jones; Heather Baird-Tomlinson; Andrew Pekosz; Paul D Olivo
Journal:  Influenza Other Respir Viruses       Date:  2009-09       Impact factor: 4.380

9.  The feasibility of using high resolution genome sequencing of influenza A viruses to detect mixed infections and quasispecies.

Authors:  Muthannan A Ramakrishnan; Zheng Jin Tu; Sushmita Singh; Ashok K Chockalingam; Marie R Gramer; Ping Wang; Sagar M Goyal; My Yang; David A Halvorson; Srinand Sreevatsan
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

10.  Broadly protective adenovirus-based multivalent vaccines against highly pathogenic avian influenza viruses for pandemic preparedness.

Authors:  Sai V Vemula; Yadvinder S Ahi; Anne-Marie Swaim; Jacqueline M Katz; Ruben Donis; Suryaprakash Sambhara; Suresh K Mittal
Journal:  PLoS One       Date:  2013-04-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.